GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders.

Martínez-Bailén M, Clemente F, Matassini C, Cardona F

DOI: 10.3390/ph15070823
Published: 2022 Jul 2
Container: Pharmaceuticals (Basel, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ph15070823,
  title = {GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders.},
  author = {Martínez-Bailén M and Clemente F and Matassini C and Cardona F},
  year = {2022},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph15070823},
  url = {https://doi.org/10.3390/ph15070823}
}

RIS

TY  - JOUR
TI  - GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders.
AU  - Martínez-Bailén M
AU  - Clemente F
AU  - Matassini C
AU  - Cardona F
PY  - 2022
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph15070823
UR  - https://doi.org/10.3390/ph15070823
ER  -

APA

M, M., F, C., C, M., & F, C. (2022). GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph15070823

Source records

pubmed · retrieved 2026-11-10T14:23:05.144Z